May 31, 2014

Q&A with Industry Leaders


Q&A's with industry leaders, from Process Development Forum 

Neil Goss, Research and Development at CSL BioPlasma, Australia, and co-author of Production of Plasma Proteins for Therapeutic Use

Rita Peters, Editorial Director of BioPharm International  

Günter Jagschies, Strategic Customer Relations Leader, GE Healthcare 

Aaron Noyes, Head of Downstream Processing at Codiak BioSciences 

John Curling, 3rd BioProcessing Asia Conference chair 

Jonathan Royce, Business Leader for GE Healthcare chromatography resins  

Andrew Sinclair, President and Founder of BioPharm Services

Greg Bolton, Scientific Director, Amgen

Rita Peters, Editorial Director of BioPharm International 

Konstantin Konstantinov, VP Late Stage Process Development, Genzyme

Rita Peters, Editorial Director of BioPharm International  

Parrish Galliher, Chief Technology Officer Upstream at GE Healthcare Life Sciences

Eric Langer, President and Managing Partner at BioPlan Associates

Phil Lester, Co-Organizer of the HTPD Conference

Dr. Anurag Rathore, Professor, Department of Chemical Engineering, Indian Institute of Technology, Delhi (Part 1)

Dr. Anurag Rathore, Professor, Department of Chemical Engineering, Indian Institute of Technology, Delhi (Part 2)

Dr. Arne Staby, Fellow, Novo Nordisk

Dr. Karol Lacki, Customer Collaborations Leader, GE Healthcare Life Sciences

Professor Alois Jungbauer, Department of Biotechnology, BOKU

Günter Jagschies, GE Healthcare

Jeff Carter, GE Healthcare

Rita Peters, Editorial Director of BioPharm International 

Eric Langer, BioPlan Associates

Tags: process development; bioprocess development; Q&A